Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aromatherapy + Standard Antiemetic Therapy for CINV in Breast Cancer
NCT07761325Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2030
01
Overview
Phase 3, randomised, open-label trial in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Complete Response Rate. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07761325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07761325.